75 related articles for article (PubMed ID: 28100393)
21. The Long Non-Coding RNA RHPN1-AS1 Promotes Uveal Melanoma Progression.
Lu L; Yu X; Zhang L; Ding X; Pan H; Wen X; Xu S; Xing Y; Fan J; Ge S; Zhang H; Jia R; Fan X
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28124977
[TBL] [Abstract][Full Text] [Related]
22. Effect of SOCS1 silencing on proliferation and apoptosis of melanoma cells: An in vivo and in vitro study.
Yu SJ; Long ZW
Tumour Biol; 2017 May; 39(5):1010428317694315. PubMed ID: 28466787
[TBL] [Abstract][Full Text] [Related]
23. A ubiquitin ligase, skeletrophin, is a negative regulator of melanoma invasion.
Takeuchi T; Adachi Y; Sonobe H; Furihata M; Ohtsuki Y
Oncogene; 2006 Nov; 25(53):7059-69. PubMed ID: 16715130
[TBL] [Abstract][Full Text] [Related]
24. Upregulated MicroRNA-25 Mediates the Migration of Melanoma Cells by Targeting DKK3 through the WNT/β-Catenin Pathway.
Huo J; Zhang Y; Li R; Wang Y; Wu J; Zhang D
Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27801786
[TBL] [Abstract][Full Text] [Related]
25. MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways.
Tang R; Xu X; Yang W; Yu W; Hou S; Xuan Y; Tang Z; Zhao S; Chen Y; Xiao X; Huang W; Guo W; Li M; Deng W
Cancer Lett; 2016 Apr; 373(1):77-87. PubMed ID: 26797421
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.
Maat W; Beiboer SH; Jager MJ; Luyten GP; Gruis NA; van der Velden PA
Invest Ophthalmol Vis Sci; 2008 Apr; 49(4):1291-8. PubMed ID: 18385040
[TBL] [Abstract][Full Text] [Related]
27. Intertumor heterogeneity in vascularity and invasiveness of artificial melanoma brain metastases.
Simonsen TG; Gaustad JV; Rofstad EK
J Exp Clin Cancer Res; 2015 Dec; 34():150. PubMed ID: 26667022
[TBL] [Abstract][Full Text] [Related]
28. RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models.
Yang H; Higgins B; Kolinsky K; Packman K; Go Z; Iyer R; Kolis S; Zhao S; Lee R; Grippo JF; Schostack K; Simcox ME; Heimbrook D; Bollag G; Su F
Cancer Res; 2010 Jul; 70(13):5518-27. PubMed ID: 20551065
[TBL] [Abstract][Full Text] [Related]
29. Exchange protein directly activated by cyclic AMP increases melanoma cell migration by a Ca2+-dependent mechanism.
Baljinnyam E; De Lorenzo MS; Xie LH; Iwatsubo M; Chen S; Goydos JS; Nowycky MC; Iwatsubo K
Cancer Res; 2010 Jul; 70(13):5607-17. PubMed ID: 20551063
[TBL] [Abstract][Full Text] [Related]
30. Testing the cancer stem cell hypothesis in melanoma: the clinics will tell.
Shakhova O; Sommer L
Cancer Lett; 2013 Sep; 338(1):74-81. PubMed ID: 23073475
[TBL] [Abstract][Full Text] [Related]
31. From the reproducibility of science to the science of reproducibility.
Arnheiter H
Pigment Cell Melanoma Res; 2017 Mar; 30(2):175-176. PubMed ID: 28324639
[No Abstract] [Full Text] [Related]
32. Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma.
Schnegg CI; Yang MH; Ghosh SK; Hsu MY
Cancer Res; 2015 Apr; 75(8):1682-90. PubMed ID: 25769726
[TBL] [Abstract][Full Text] [Related]
33. CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.
Tse KF; Jeffers M; Pollack VA; McCabe DA; Shadish ML; Khramtsov NV; Hackett CS; Shenoy SG; Kuang B; Boldog FL; MacDougall JR; Rastelli L; Herrmann J; Gallo M; Gazit-Bornstein G; Senter PD; Meyer DL; Lichenstein HS; LaRochelle WJ
Clin Cancer Res; 2006 Feb; 12(4):1373-82. PubMed ID: 16489096
[TBL] [Abstract][Full Text] [Related]
34. Genetically engineered mesenchymal stromal cells producing TNFα have tumour suppressing effect on human melanoma xenograft.
Tyciakova S; Matuskova M; Bohovic R; Polakova K; Toro L; Skolekova S; Kucerova L
J Gene Med; 2015; 17(1-2):54-67. PubMed ID: 25677845
[TBL] [Abstract][Full Text] [Related]
35. Interaction of extracellular S100A4 with RAGE prompts prometastatic activation of A375 melanoma cells.
Herwig N; Belter B; Wolf S; Haase-Kohn C; Pietzsch J
J Cell Mol Med; 2016 May; 20(5):825-35. PubMed ID: 26928771
[TBL] [Abstract][Full Text] [Related]
36. Regulation of ERK3/MAPK6 expression by BRAF.
Hoeflich KP; Eby MT; Forrest WF; Gray DC; Tien JY; Stern HM; Murray LJ; Davis DP; Modrusan Z; Seshagiri S
Int J Oncol; 2006 Oct; 29(4):839-49. PubMed ID: 16964379
[TBL] [Abstract][Full Text] [Related]
37. Pegylated and conventional interferon-alpha induce comparable transcriptional responses and inhibition of tumor growth in a human melanoma SCID mouse xenotransplantation model.
Krepler C; Certa U; Wacheck V; Jansen B; Wolff K; Pehamberger H
J Invest Dermatol; 2004 Oct; 123(4):664-9. PubMed ID: 15373770
[TBL] [Abstract][Full Text] [Related]
38. miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule.
Wang HF; Chen H; Ma MW; Wang JA; Tang TT; Ni LS; Yu JL; Li YZ; Bai BX
Oncol Rep; 2013 Jul; 30(1):520-6. PubMed ID: 23670160
[TBL] [Abstract][Full Text] [Related]
39. Mechanistic insights into the role of truncating PREX2 mutations in melanoma.
Lissanu Deribe Y
Mol Cell Oncol; 2016 May; 3(3):e1160174. PubMed ID: 27314100
[TBL] [Abstract][Full Text] [Related]
40. Mouse avatars take off as cancer models.
Nilsson JA; Olofsson Bagge R; Ny L
Nature; 2018 Oct; 562(7726):192. PubMed ID: 30305752
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
